Authors: BLACK DM BAKKERARKEMA R HEINONEN T NAWROCKI JW

Citation: Dm. Black et al., EFFICACY AND SAFETY OF ATORVASTATIN IN HYPERLIPIDEMIC PATIENTS WITH CONCURRENT HYPERTENSION OR NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of hypertension, 16, 1998, pp. 31018-31018

Authors: BLACK D DAVIDSON M KOREN M BAKKERARKEMA R TRESH P MCLAIN R SMITH D HUNNINGHAKE D

Citation: D. Black et al., COST-EFFECTIVENESS OF TREATMENT TO NATIONAL CHOLESTEROL EDUCATION PANEL (NCEP) TARGETS WITH HMG-COA REDUCTASE INHIBITORS - TRIAL DESIGN, PharmacoEconomics, 12(2), 1997, pp. 278-285

Authors: DAVIDSON M MCKENNEY J STEIN E SCHROTT H BAKKERARKEMA R FAYYAD R BLACK D

Citation: M. Davidson et al., COMPARISON OF ONE-YEAR EFFICACY AND SAFET Y OF ATORVASTATIN VERSUS LOVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA, Perfusion, 10(10), 1997, pp. 344-352

Authors: DAVIDSON M MCKENNEY J STEIN E SCHROTT H BAKKERARKEMA R FAYYAD R BLACK D

Citation: M. Davidson et al., COMPARISON OF ONE-YEAR EFFICACY AND SAFETY OF ATORVASTATIN VERSUS LOVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA, The American journal of cardiology, 79(11), 1997, pp. 1475-1481